Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpes Simplex Type 2”

47 trials

Showing 20 of 47 results

Not applicableStudy completedNCT01460433
What this trial is testing

Problems With Immune Recovery in the Gut Tissue

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 21
Not applicableWithdrawnNCT04294030
What this trial is testing

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
HSV-2 InfectionHerpes Simplex Virus Infection
NOWDiagnostics, Inc.
Testing effectiveness (Phase 2)Study completedNCT06033261
What this trial is testing

MRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Who this might be right for
Genital Herpes
ModernaTX, Inc. 365
Large-scale testing (Phase 3)Study completedNCT00860977
What this trial is testing

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Who this might be right for
HIV InfectionHerpes Simplex Type IIHIV Infections
University Health Network, Toronto 202
Testing effectiveness (Phase 2)Study completedNCT01687595
What this trial is testing

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

Who this might be right for
Herpes Simplex Type 2
Agenus Inc. 80
Not applicableStudy completedNCT01315054
What this trial is testing

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Who this might be right for
HIVHepatitis CSyphilis+1 more
Centers for Disease Control and Prevention 4,258
Testing effectiveness (Phase 2)Study completedNCT02030301
What this trial is testing

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Who this might be right for
Genital Herpes Simplex Type 2
Vical 165
Not applicableStudy completedNCT00803543
What this trial is testing

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Who this might be right for
HIVHIV Infections
University of Alabama at Birmingham 103
Not applicableStudy completedNCT00495573
What this trial is testing

HSV-2 Shedding Resolution After Acyclovir Treatment

Who this might be right for
Genital Herpes
University of Washington 36
Testing effectiveness (Phase 2)Ended earlyNCT04637698
What this trial is testing

OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Binhui Biopharmaceutical Co., Ltd. 5
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Not applicableStudy completedNCT01043081
What this trial is testing

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Who this might be right for
Sexually Transmitted InfectionsHIV Infections
University of Mississippi Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT02837575
What this trial is testing

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Who this might be right for
Herpes Genitalis
Vical 261
Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Early research (Phase 1)Active Not RecruitingNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Testing effectiveness (Phase 2)Study completedNCT02114060
What this trial is testing

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Early research (Phase 1)Active Not RecruitingNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 146
Testing effectiveness (Phase 2)Looking for participantsNCT03866525
What this trial is testing

OH2 Oncolytic Viral Therapy in Solid Tumors

Who this might be right for
Solid TumorGastrointestinal Cancer
Binhui Biopharmaceutical Co., Ltd. 300
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation